All sponsors

Hangzhou Sciwind Biosciences Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS7
PHASE 3 / 2-34
RECRUITING4
READOUTS ≤12 MONTHS3
Open Hangzhou Sciwind Biosciences Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
ecnoglutide tablets
NCT07243171
P1/2RecruitingOverweight and/or Obesity; Weight Management1262027-01-05
XW003 injection
NCT07073417
P2Active, not recruitingObesity; Weight Management1632027-02-27
ecnoglutide tablet
NCT07929298
P2Not yet recruitingOverweight , Obesity; Weight Management1802027-09-03
XW003 injection
NCT07387094
P3RecruitingOSA - Obstructive Sleep Apnea; Obesity1402027-12-16
Ecnoglutide Injection
NCT07734311
P3RecruitingKnee Osteoarthritis; Obesity3602028-05-31
Ecnoglutide Injection
NCT07836270
P3Not yet recruitingAdolescents With Obesity; Adolescents With Overweight & Weight-related Comorbidities1922028-06-08
XW003 injection
NCT07434050
P3RecruitingOSA - Obstructive Sleep Apnea; Obesity1402028-06-19